Brief: Sorrento Says Covishield (Sti-9167) Antibody Neutralizes BA.2 Omicron Sublineage Virus, Others
22/02/2022 14:24
Feb 22 (Reuters) - Sorrento Therapeutics Inc SRNE.O :
* SORRENTO ANNOUNCES COVISHIELD (STI-9167) ANTIBODY STRONGLY
NEUTRALIZES BA.2 OMICRON SUBLINEAGE VIRUS AS WELL AS BA.1 AND
BA.1+R346K OMICRON VIRUSES
Source text for Eikon: ID:nGNX9Z9xlb
Further company coverage: SRNE.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Sorrento Therapeutics
See all newsBrief: Scilex Holding Says US Bankruptcy Court Extended Lockup Period On Shares Of Scilex Stock
Company's PO box allows it to file for bankruptcy in Texas, judge rules
Latham, Jackson Walker avoid sanctions over bankruptcy forum shopping dispute (updated)
Latham, Jackson Walker avoid sanctions over bankruptcy forum shopping dispute
Brief: Sorrento Therapeutics Reduced U.S. Headcount From 215 To 128 on Sept. 20